Literature DB >> 25612180

HIV prevention: integrating biomedical and behevioral interventions.

Carlos Del Rio1.   

Abstract

Recommendations for HIV prevention in clinical care settings by an IAS-USA panel were recently published. They include recommendations on HIV testing, antiretroviral therapy initiation, risk-reduction counseling, and antiretroviral therapy adherence counseling for HIV-infected individuals. For individuals at risk for HIV infection, recommendations for preexposure prophylaxis, other risk-reduction strategies, adherence counseling, and postexposure prophylaxis are included. Many HIV-infected individuals in the United States are not fully engaged in HIV care and are not virologically suppressed, thus a crucial component of efforts to reduce HIV transmission is moving patients through the HIV care continuum. This article summarizes an IAS-USA continuing education webinar presented by Carlos del Rio, MD, in September 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25612180      PMCID: PMC6148895     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  19 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

Review 3.  Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.

Authors:  Andrew Anglemyer; George W Rutherford; Matthias Egger; Nandi Siegfried
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

4.  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Preexposure prophylaxis for HIV infection among African women.

Authors:  Lut Van Damme; Amy Corneli; Khatija Ahmed; Kawango Agot; Johan Lombaard; Saidi Kapiga; Mookho Malahleha; Fredrick Owino; Rachel Manongi; Jacob Onyango; Lucky Temu; Modie Constance Monedi; Paul Mak'Oketch; Mankalimeng Makanda; Ilse Reblin; Shumani Elsie Makatu; Lisa Saylor; Haddie Kiernan; Stella Kirkendale; Christina Wong; Robert Grant; Angela Kashuba; Kavita Nanda; Justin Mandala; Katrien Fransen; Jennifer Deese; Tania Crucitti; Timothy D Mastro; Douglas Taylor
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

8.  HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Authors:  Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

9.  No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.

Authors:  Julia L Marcus; David V Glidden; Kenneth H Mayer; Albert Y Liu; Susan P Buchbinder; K Rivet Amico; Vanessa McMahan; Esper Georges Kallas; Orlando Montoya-Herrera; Jose Pilotto; Robert M Grant
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.

Authors:  Teri Liegler; Mohamed Abdel-Mohsen; L Gordon Bentley; Robert Atchison; Timothy Schmidt; Jacqueline Javier; Megha Mehrotra; Christopher Eden; David V Glidden; Vanessa McMahan; Peter L Anderson; Peilin Li; Joseph K Wong; Susan Buchbinder; Juan V Guanira; Robert M Grant
Journal:  J Infect Dis       Date:  2014-04-16       Impact factor: 5.226

View more
  3 in total

1.  Missed opportunities for HIV control: Gaps in HIV testing for partners of people living with HIV in Lima, Peru.

Authors:  Ana L Vasquez; Renato A Errea; Daniel Hoces; Juan Echevarria; Elsa González-Lagos; Eduardo Gotuzzo
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

2.  Demographic characteristics associated with the use of HIV pre-exposure prophylaxis (PrEP) in an urban, community health center.

Authors:  Mitchell Caponi; Carolyne Burgess; Alexandra Leatherwood; Luis Freddy Molano
Journal:  Prev Med Rep       Date:  2019-05-14

3.  Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men.

Authors:  Pamela Valera; Zaire S Ali; Diamond Cunningham; Christopher McLaughlin; Sebastian Acevedo
Journal:  Am J Mens Health       Date:  2022 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.